The fraud estimate provided at yesterday's parliamentary inquiry reframes the debate. If billions of dollars are being lost to fraud, the argument for reform might shift from spending restraint to recovering funds diverted by criminality, but officials essentially admitted that the problem is too big to eliminate by prosecution.
NDIS fraud is so extensive that 'prosecuting our way out of it' is now impractical
April 24, 2026 Latest NewsBioPharmaOther Health
Latest Video
New Stories
-
Algorae names Nasdaq pharmaceutical chairman to strengthen board
July 15, 2026 - - Australian Biotech -
Starpharma raises $32 Million to advance dendrimer cancer programs
July 15, 2026 - - Australian Biotech -
Minister recommits to keeping MS medicines on the PBS while awaiting formal advice
July 15, 2026 - - Latest News -
Budget outlook now hangs on disability savings, but what about pharmaceuticals
July 15, 2026 - - Latest News -
Australian partnership advances gene therapy for Retinitis Pigmentosa
July 15, 2026 - - Latest News -
Patients move to reclaim access agenda ahead of sector negotiations
July 15, 2026 - - Latest News -
An opportunity to become a global destination for paediatric oncology trials
July 15, 2026 - - Latest News

